Khon Kaen Sugar Industry PCL (KSL)
Thailand Exchange · Thailand · prices in THB · close of 22 Oct 2026
Key indicators
| Last close | THB 1.760 |
|---|---|
| 52-week range | 1.190 – 2.080 |
| Return, 1 month / 3 months | −0.6% / +10.0% |
| Return, 1 year / 3 years | +31.5% / −31.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 38.2% |
| Worst drawdown (1 year) | -18.0% |
| Average daily value traded | 8.27M THB |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Khon Kaen Sugar Industry is a Thai sugar producer based in the northeast of the country. The company operates sugar mills and refineries that turn sugarcane into raw and refined sugar for food and beverage manufacturers and other industrial users. Alongside sugar, it produces ethanol and generates electricity from bagasse, the fibrous residue left after cane is crushed, and it also runs operations in neighbouring countries.
Khon Kaen Sugar Industry PCL trades under the code KSL on the Thailand Exchange in Thailand, with its price quoted in Thai baht (THB). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Khon Kaen Sugar Industry PCL (KSL) trades on the Thailand Exchange in Thailand. It last closed at THB 1.760 on 22 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 216 of 1,349 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.5% and over the last three months it rose 10.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Thailand Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.6% | ||
| From 52-week high | -11.1% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.0% | ||
| 6-month return | 23.1% | ||
| 12-month return, skipping the last month | 32.2% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.0% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 8.27M THB | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −0.6% |
| 3 months | +10.0% |
| 6 months | +23.1% |
| 1 year | +31.5% |
| 3 years | −31.3% |
| 5 years | −48.7% |
Signals
| 50-day / 200-day average | 1.817 / 1.536 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.056 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Mar 2026 | THB 0.0400 |
| 28 Feb 2025 | THB 0.0500 |
| 29 Feb 2024 | THB 0.0500 |
| 2 Mar 2023 | THB 0.0700 |
| 22 Sep 2022 | THB 0.0300 |
| 3 Mar 2022 | THB 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Thailand Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.